[
    [
        {
            "time": "",
            "original_text": "医药行业周报：板块回调 关注低估值、高业绩确定性细分龙头",
            "features": {
                "keywords": [
                    "医药",
                    "板块回调",
                    "低估值",
                    "高业绩确定性",
                    "细分龙头"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业周报：板块回调 关注低估值、高业绩确定性细分龙头",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-11",
            "original_text": "港股盘前必读：中通快递9月11日正式通过港交所上市聆讯",
            "features": {
                "keywords": [
                    "港股",
                    "中通快递",
                    "上市聆讯"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "物流"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股盘前必读：中通快递9月11日正式通过港交所上市聆讯",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "泰格医药上市8年净利股价双增30倍 15亿外延并购成国内CRO企业龙头",
            "features": {
                "keywords": [
                    "泰格医药",
                    "上市8年",
                    "净利股价双增",
                    "外延并购",
                    "CRO企业龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药上市8年净利股价双增30倍 15亿外延并购成国内CRO企业龙头",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]